Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Lippo Karawaci Tbk (PTLKF) Fair Value & Analysis

Healthcare · US · Market cap $35.4M

Price$0.0100
Fair Value$0.0091
Upside-9.4%
Quality92/100
Evidence: High Range $0.0091 – $0.0091

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PT Lippo Karawaci Tbk (PTLKF) currently trades at $0.0100, while our model-based Fair Value estimate is $0.0091 — implying the stock looks roughly 9.4% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

PT Lippo Karawaci Tbk engages in real estate development, healthcare and lifestyle businesses in Indonesia. The company is also involved in investment, development, trading, home care, and financing activities; installation and water treatment; town management; urban development; marketing and building management; clean water and waste management; hotel management; catering service; and provision of accommodation and burial services. PT Lippo Karawaci Tbk founded in 1990 and is based in Tangerang, Indonesia.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -73% Fresenius SE (FSNUY) -25% 5225 (5225) -70% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) -7% Tenet Healthcare Corporation (THC) +74%

Frequently asked questions

Is PT Lippo Karawaci Tbk (PTLKF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0091 versus a price of $0.0100 — about −9% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PTLKF?
Our 21-model fair value for PT Lippo Karawaci Tbk is $0.0091 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0100.
What is the quality score of PTLKF?
PT Lippo Karawaci Tbk has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.